sameAs
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotationThe safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary diseaseHuman saliva, plasma and breast milk exosomes contain RNA: uptake by macrophagesAirway allergen exposure stimulates bone marrow eosinophilia partly via IL-9.Outer membrane vesicles derived from Escherichia coli up-regulate expression of endothelial cell adhesion molecules in vitro and in vivoExosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsUltra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary diseaseOsteopontin expression and relation to disease severity in human asthmaRandomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitisWe Call for iCAALL: International Collaboration in Asthma, Allergy and ImmunologyImmunophenotyping of circulating T helper cells argues for multiple functions and plasticity of T cells in vivo in humans--possible role in asthmaExosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNAInternational consensus on (ICON) pediatric asthmaEAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.Relationship between systemic blood pressure, airway blood flow and plasma exudation in guinea-pig.EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesiclesMotivational foci and asthma medication tactics directed towards a functional dayOnset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers.Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroidsIncreased prevalence of symptoms of rhinitis but not of asthma between 1990 and 2008 in Swedish adults: comparisons of the ECRHS and GA²LEN surveys.The influence of personality traits on reported adherence to medication in individuals with chronic disease: an epidemiological study in West Sweden.Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.Inhalation therapy of the future--how will it change the way we treat asthma?Pharmacological similarities and differences between beta2-agonists.Standardization of sample collection, isolation and analysis methods in extracellular vesicle research.Mast cell exosomes promote lung adenocarcinoma cell proliferation - role of KIT-stem cell factor signalingMulti-symptom asthma is closely related to nasal blockage, rhinorrhea and symptoms of chronic rhinosinusitis-evidence from the West Sweden Asthma Study.Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles.Modulation of allergen-induced bronchoconstriction by fluticasone furoate and vilanterol alone or in combination.Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways.Higher risk of wheeze in female than male smokers. Results from the Swedish GA 2 LEN study.Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial.Frequent cough in unsatisfactory controlled asthma--results from the population-based West Sweden Asthma study.Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea.The long and short of beta2-agonists.Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinasesMicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma.Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial.Murine models of asthma.
P50
Q21145728-2195F9D9-4024-451F-9FE9-788ED5D6DF1BQ22305858-7D8EFB1F-6FF8-4BA7-A59A-AF0383D43F0CQ24337080-82C25BD1-6C84-476D-ADEB-0B1304394B0AQ24800600-36CC11DF-A810-482D-B896-0771D906E237Q27334047-5A069C5E-E765-4D13-8FED-51C68DED9BB0Q27860960-28E44D20-EC9E-47F3-B5AB-FC0AE3A149C9Q28261960-94F69319-A5E4-490F-9C98-4C2D122B0EECQ28285703-0996B5FD-C6C9-4CE0-9704-6EC3625EF00DQ28377209-351D2B85-AC88-454C-A558-70AD522BAE0DQ28710511-C84F9F4A-A970-43BD-94B3-36FAC409E9B4Q28727782-D25A6F68-26FA-4722-BB8B-098EE6501AB3Q28744122-ACEE750D-0090-450A-8CB2-293823597C0DQ30393965-D92680A6-9831-4BDC-ACEC-88DBEA4EE38EQ30394524-E89A7162-B70A-4DC6-AAE1-16BE1863ED86Q30656834-F8727446-AE92-4409-A9FA-4C88E2D7575CQ30665295-F59F2642-39DD-416B-AC89-CFD3838C9506Q31039001-A3FCA79F-AAD2-4DF3-9AB8-93E2B7B5ED23Q31854727-1A507A81-CE97-4D70-91E3-D82BD8DBAB16Q33749702-4E12C662-4C85-4424-A079-C08EB30C6E78Q33838329-21A31837-8AFD-4D88-BFD8-12EE979E0C53Q33862473-301659AC-7855-445C-8919-FCFEA47C5443Q33937441-7AF1119B-5C33-4008-9575-1A7C912711CDQ34292661-922533B8-B4CC-48CD-902C-FBA37638A0F8Q34292661-A6557106-F299-4EF4-9757-F84808F52454Q34354908-4D0FA0E2-5232-4197-8E43-286F901FB5A3Q34369038-D5A38D57-2CEC-4A4F-B2B5-086AEC70F95AQ34389651-5410BB15-A483-4D7F-AD10-A4CBDD0B77BCQ34419181-15A1AC78-138A-4553-862C-B999FD7B295AQ34455456-FA746749-A793-48E5-8EF5-72D9ECB14C14Q34470553-F25B0E1A-E8BB-487E-8076-B74B09C00860Q34492076-D049E158-C1D2-4F08-A71F-A93BD34EF9B2Q34565841-FD0C82B2-ECC1-4AD1-8F0E-8236E9F9FC54Q34636952-E278BCD8-F1F6-4463-B240-8AF8C8AE0C17Q34672401-7162AEE3-DE21-4513-9B6F-B844091BFDE9Q34793042-FD2DB1BF-398F-4952-B084-E50356D42EEFQ35031187-B6CA533D-94F8-4021-95B1-04DB45F183D3Q35039844-683F2E8A-4F73-480D-9736-32AB4448339BQ35043470-0F2F7D66-36AC-43E9-AE3A-9F7EDF59B37CQ35060575-F4B324F8-6D3E-40E8-A3A4-B8EFAF02EEC1Q35086014-A0FBD2CF-0CDB-459B-A827-4018C6390095
P50
description
Swedish clinical allergist
@en
Zweeds arts
@nl
dokter asal Swedia
@id
médicu suecu
@ast
schwedischer Arzt
@de
svensk läkare
@sv
طبيب سويدي
@ar
name
Jan Lötvall
@ast
Jan Lötvall
@ca
Jan Lötvall
@de
Jan Lötvall
@en
Jan Lötvall
@es
Jan Lötvall
@fr
Jan Lötvall
@ga
Jan Lötvall
@nl
Jan Lötvall
@sl
Jan Lötvall
@sq
type
label
Jan Lötvall
@ast
Jan Lötvall
@ca
Jan Lötvall
@de
Jan Lötvall
@en
Jan Lötvall
@es
Jan Lötvall
@fr
Jan Lötvall
@ga
Jan Lötvall
@nl
Jan Lötvall
@sl
Jan Lötvall
@sq
prefLabel
Jan Lötvall
@ast
Jan Lötvall
@ca
Jan Lötvall
@de
Jan Lötvall
@en
Jan Lötvall
@es
Jan Lötvall
@fr
Jan Lötvall
@ga
Jan Lötvall
@nl
Jan Lötvall
@sl
Jan Lötvall
@sq
P214
P106
P1153
56236420900
P21
P214
P27
P31
P496
0000-0001-9195-9249
P569
1956-12-07T00:00:00Z
P734
P735
P7859
lccn-n2011182953